Instem (INS)

 

INS Share PerformanceMore

52 week high328.55 26/09/16
52 week low155.00 30/08/17
52 week change -128.00 (-43.03%)
4 week volume55,623 27/08/17

Media for (INS)

Presenter: Phil Reason, CEO
04/02/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 4983R Instem plc 21 September 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: INSTEM Plc 1b. Please in...

Notice of Results

RNS Number: 6465P Instem plc 04 September 2017 Instem plc Notice of Results Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will announce half year results for the six months ended 30 June 2017 on Tuesday 26 th September 2017. Management will be hosting a presentation for analysts on the day of the r...

Issue of Equity, TVRs & PDMR Dealing

RNS Number: 2507L Instem plc 17 July 2017 Instem plc (" Instem " or the " Company ") Issue of Equity, Total Voting Rights and PDMR Dealing Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that, following the exercise of vested EMI share options by an employee, 1,500 ordinary shares of 10p ea...

Payment of consideration and total voting rights

RNS Number: 6631G Instem plc 31 May 2017 Instem plc ("Instem" or the "Company") Samarind Deferred Consideration Payment and Total Voting Rights Instem (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that the first deferred consideration payment of 450,000 in respect of the acquisition of Samarind...

Holding(s) in Company

RNS Number: 7279F Instem plc 19 May 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii INSTEM PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal o...

All resolutions passed at AGM of Instem

Instem has announced that, at its Annual General Meeting held earlier today, all resolutions were passed. At 2:59pm: (LON:I...

Result of AGM

RNS Number: 5426F Instem plc 18 May 2017 Instem plc ("Instem") Result of Annual General Meeting Instem plc (AIM: INS.L), a leading provider ofIT solutionsto the global early development healthcare market,announces that at its Annual General Meeting, held today, all resolutions were duly passed. For further information, please contact: Instem plc +44 (0) 1785 825...

Holding(s) in Company

RNS Number: 7761D Instem plc 28 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Instem PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal o...

Fundamental DataMore

P/E ratio24.565
EPS6.9
Dividend yield0 %

Equity Research (INS)

progressive research
Instem plc
13/04/2017
Instem’s FY 16A results were line with the Jan-17 trading update and our forecasts. Excluding the Clinical business, performance remains solid, particularly in pre-clinical and the SEND businesses....
progressive research
Instem plc
16/01/2017
Instem has published a short trading update for the year to December 2016. The outcome was in line with (and in some areas slightly ahead of) our expectations. The year was impacted by the slowdown...
progressive research
Instem plc
21/12/2016
Instem recently confirmed that its Instem Clinical business continues to be impacted by a slowdown in the early-phase clinical market and, despite other areas of Instem performing well, that this...

Latest discussion posts More

  • NEW ARTICLE: Instem worth 24% more

    "I first spoke to LSE:INS:Instem early last year. The AIM-listed company was worth A#22 million and demand for its software, which helps drug companies develop commercial drugs ...
    19-Sep-2016
    II Editor

Users' HoldingsMore

Users who hold Instem also hold..
AMEC FOSTER45%
BT GROUP45%
LLOYDS GRP.36%
VECTURA36%
GLAXOSMITHKLINE36%

Codes & Symbols

ISINGB00B3TQCK30
SymbolsINS, LSE:INS, INS.L, INS:LN, LON:INS, XLON:INS